$APVO
Aptevo Therapeutics Inc.

2017 Q4 Form 10-K Financial Statement

#000156459018005384 Filed on March 13, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $2.820M $10.95M $8.769M
YoY Change -67.84% 11.67% 5.83%
Cost Of Revenue $1.900M $5.010M $5.080M
YoY Change -62.6% -79.28% -3.05%
Gross Profit $920.0K $9.650M -$2.300M
YoY Change -140.0% -167.12% -175.41%
Gross Profit Margin 32.62% 88.14% -26.23%
Selling, General & Admin $8.560M $34.58M $8.210M
YoY Change 4.26% -10.58% -41.94%
% of Gross Profit 930.43% 358.3%
Research & Development $9.190M $29.02M $6.360M
YoY Change 44.5% -1.68% -14.17%
% of Gross Profit 998.91% 300.74%
Depreciation & Amortization $140.0K $3.127M $450.0K
YoY Change -68.89% -6.99% -44.44%
% of Gross Profit 15.22% 32.4%
Operating Expenses $17.74M $63.60M $14.57M
YoY Change 21.76% -6.73% -32.39%
Operating Profit -$16.82M -$53.95M -$14.55M
YoY Change 15.58% -61.12% -21.34%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$590.0K -$1.944M -$390.0K
YoY Change 51.28% 140.0% 3800.0%
Pretax Income -$17.41M -$55.89M -$14.95M
YoY Change 16.49% -59.96% -19.25%
Income Tax -$7.690M -$23.30M -$1.100M
% Of Pretax Income
Net Earnings -$9.760M $6.973M -$14.95M
YoY Change -34.7% -106.2% -16.49%
Net Earnings / Revenue -346.1% 63.69% -170.44%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.217M $4.586M -$10.31M
COMMON SHARES
Basic Shares Outstanding 20.25M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.78M $80.80M $54.50M
YoY Change 48.23% 48.26% 1084.78%
Cash & Equivalents $7.095M $7.100M $9.676M
Short-Term Investments $73.69M $73.70M $44.80M
Other Short-Term Assets $6.710M $11.10M $2.026M
YoY Change 231.19% -31.06% -11.91%
Inventory $1.028M $1.000M $6.639M
Prepaid Expenses $4.022M
Receivables $2.141M $2.100M $4.284M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $95.08M $95.10M $71.41M
YoY Change 33.14% 33.19% 103.26%
LONG-TERM ASSETS
Property, Plant & Equipment $5.843M $5.800M $5.910M
YoY Change -1.13% -1.69% 41.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00M $10.00M $7.600M
YoY Change 31.58% 31.58%
Total Long-Term Assets $21.92M $21.90M $20.44M
YoY Change 7.23% 6.83% -77.93%
TOTAL ASSETS
Total Short-Term Assets $95.08M $95.10M $71.41M
Total Long-Term Assets $21.92M $21.90M $20.44M
Total Assets $117.0M $117.0M $91.86M
YoY Change 27.38% 27.31% -28.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.400M $7.400M $10.50M
YoY Change -29.52% -29.52% 3.96%
Accrued Expenses $4.600M $4.600M $4.000M
YoY Change 15.0% 15.0% 21.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.333M $3.300M $0.00
YoY Change
Total Short-Term Liabilities $18.51M $18.50M $19.54M
YoY Change -5.29% -5.13% -2.0%
LONG-TERM LIABILITIES
Long-Term Debt $15.73M $15.70M $18.38M
YoY Change -14.44% -14.67%
Other Long-Term Liabilities $734.0K $700.0K $469.0K
YoY Change 56.5% -79.41% 560.56%
Total Long-Term Liabilities $16.46M $16.40M $18.85M
YoY Change -12.68% -24.77% 26452.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.51M $18.50M $19.54M
Total Long-Term Liabilities $16.46M $16.40M $18.85M
Total Liabilities $34.97M $35.00M $41.29M
YoY Change -15.31% -15.25% 5.47%
SHAREHOLDERS EQUITY
Retained Earnings -$73.72M -$80.69M
YoY Change -8.64% -65.22%
Common Stock $155.9M $151.3M
YoY Change 3.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $82.04M $82.00M $50.57M
YoY Change
Total Liabilities & Shareholders Equity $117.0M $117.0M $91.86M
YoY Change 27.38% 27.31% -28.11%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$9.760M $6.973M -$14.95M
YoY Change -34.7% -106.2% -16.49%
Depreciation, Depletion And Amortization $140.0K $3.127M $450.0K
YoY Change -68.89% -6.99% -44.44%
Cash From Operating Activities -$15.42M -$41.57M -$6.660M
YoY Change 131.53% 12.79% -13.28%
INVESTING ACTIVITIES
Capital Expenditures -$290.0K $1.402M -$580.0K
YoY Change -50.0% -44.19% 11.54%
Acquisitions
YoY Change
Other Investing Activities -$53.54M $30.86M $4.920M
YoY Change -1188.21% -168.76%
Cash From Investing Activities -$53.84M $29.46M $4.350M
YoY Change -1337.7% -162.16% -936.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $442.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.52M 19.53M 1.110M
YoY Change 847.75% -78.13% -88.14%
NET CHANGE
Cash From Operating Activities -15.42M -41.57M -6.660M
Cash From Investing Activities -53.84M 29.46M 4.350M
Cash From Financing Activities 10.52M 19.53M 1.110M
Net Change In Cash -58.74M 7.419M -1.200M
YoY Change 4795.0% 46.91% -203.45%
FREE CASH FLOW
Cash From Operating Activities -$15.42M -$41.57M -$6.660M
Capital Expenditures -$290.0K $1.402M -$580.0K
Free Cash Flow -$15.13M -$42.98M -$6.080M
YoY Change 148.85% 9.15% -15.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21112605
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
73688000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7095000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2141000
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q2 dei Entity Public Float
EntityPublicFloat
35800000
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
44849000
CY2017Q4 us-gaap Inventory Net
InventoryNet
1028000
CY2016Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
10155000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
400000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
400000
CY2017Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4022000
CY2016Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3540000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2026000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
10000000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3362000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-72000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6901000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3809000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4884000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6080000
CY2017Q4 us-gaap Assets
Assets
117007000
CY2017Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
7350000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4626000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3201000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
278000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18510000
CY2017 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21605716
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5843000
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
7624000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
811000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2016Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
3928000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2896000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33000
CY2016Q4 apvo Contribution Receivable From Former Parent
ContributionReceivableFromFormerParent
20000000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73719000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80692000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
82035000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
50566000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117007000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
91858000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20271737
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21605716
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20271737
CY2017 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10949000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9805000
CY2017 apvo Collaborations Revenue
CollaborationsRevenue
3709000
CY2016 apvo Collaborations Revenue
CollaborationsRevenue
180000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34576000
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
71013000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-53949000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-138773000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1944000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-810000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1944000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-810000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55893000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-139583000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23301000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19692000
CY2017 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-32592000
CY2017 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
62864000
CY2016 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
11828000
CY2017 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
23299000
CY2016 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
4352000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
4884000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3127000
CY2017 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
52697000
CY2016 apvo Impairment Of Goodwill And I Itangible Assets
ImpairmentOfGoodwillAndIItangibleAssets
71013000
CY2017 apvo Non Cash Interest Expense
NonCashInterestExpense
925000
CY2017 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-287000
CY2017 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2000
CY2016 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-15817000
CY2016 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-444000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1834000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
567000
CY2016 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
1376000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
162000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
88618000
CY2016 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
20000
CY2016 apvo Stockholders Equity Transfers From Former Parent
StockholdersEquityTransfersFromFormerParent
70529000
CY2017 apvo Stockholders Equity Transfers From Former Parent
StockholdersEquityTransfersFromFormerParent
20000000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
440000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-756000
CY2017 apvo Increase Decrease In Assets And Liabilities Held For Sale
IncreaseDecreaseInAssetsAndLiabilitiesHeldForSale
-2700000
CY2016 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
400000
CY2017 apvo Increase Decrease In Sales Rebates And Discounts
IncreaseDecreaseInSalesRebatesAndDiscounts
-345000
CY2016 apvo Increase Decrease In Sales Rebates And Discounts
IncreaseDecreaseInSalesRebatesAndDiscounts
-997000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3707000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3454000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-41573000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-36862000
CY2017 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
70730000
CY2017 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
59763000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1402000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2512000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
99633000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
44882000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
29458000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-47394000
CY2016 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
71219000
CY2017 apvo Settlement Of Contribution Receivable From Former Parent
SettlementOfContributionReceivableFromFormerParent
20000000
CY2017 apvo Proceeds From Long Term Debt Net Of Issuance Costs And Modification Fees
ProceedsFromLongTermDebtNetOfIssuanceCostsAndModificationFees
-150000
CY2016 apvo Proceeds From Long Term Debt Net Of Issuance Costs And Modification Fees
ProceedsFromLongTermDebtNetOfIssuanceCostsAndModificationFees
18038000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
38000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
758000
CY2017 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-10000000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9534000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
89295000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2581000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5039000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4637000
CY2017 us-gaap Interest Paid
InterestPaid
1778000
CY2016 us-gaap Interest Paid
InterestPaid
537000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
1359000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p></div>
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Financial instruments that potentially subject Aptevo to concentrations of credit risk consist primarily of cash and cash equivalents, certain investments and accounts receivable. Aptevo places its cash and cash equivalents with high quality financial institutions and may maintain cash balances in excess of insured limits. Management believes that the financial risks associated with its cash and cash equivalents are minimal.</p></div>
CY2017 us-gaap Revenue Recognition Revenue Reductions
RevenueRecognitionRevenueReductions
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Product Sales, Rebates and other Discounts</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aptevo markets and sells its product through commercial wholesalers (direct customers) who purchase the product at a price referred to as the wholesale acquisition cost (WAC). Additionally, Aptevo may enter into separate agreements with indirect customers to acquire its product for a contracted price that is less than the product&#8217;s WAC. The indirect customers, such as group-purchasing organizations, physician practice-management groups and hospitals, continue to purchase Aptevo&#8217;s product from the wholesalers, but at their respective contractual prices. Per its wholesaler agreements, Aptevo guarantees to credit the wholesaler for the difference between the WAC and the indirect customers&#8217; contracted price. This credit is referred to as a chargeback and revenues from product sales are recorded net of estimated chargebacks. Adjustments to the chargeback provisions are made periodically to reflect new facts and circumstances, therefore historical experience may not be indicative of current and/or future results.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All revenues from product sales are also recorded net of applicable allowances for sales and government rebates, special promotional programs, and discounts. Management does not believe there to be a legal right of offset related to these allowances and the receivables from wholesalers; accordingly, allowances are classified as a current liability in the accompanying balance sheets. These allowances are estimated based on historical payment experience, historical relationship to revenues, estimated customer inventory levels, contract terms, and actual discounts offered. In arriving at these estimates, Aptevo further utilizes information received from third parties including market data, inventory reports from major wholesalers, historical information and analysis. These estimates are subject to the inherent limitations of estimates that rely on third-party data, as certain third-party information may itself rely on estimates and reflect other limitations.</p></div>
CY2017 apvo Number Of Revenue Generating Product
NumberOfRevenueGeneratingProduct
1
CY2017 apvo Entity Incorporation Month And Year Of Incorporation
EntityIncorporationMonthAndYearOfIncorporation
2016-02
CY2017 apvo Date Of Spinoff
DateOfSpinoff
2016-08-01
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10400000
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
84685000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
50064000
CY2017Q4 apvo Amount Of Money Market Funds Included In Restricted Cash
AmountOfMoneyMarketFundsIncludedInRestrictedCash
10000000
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
56000
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
260000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
482000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
490000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
197000
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
7100000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13367000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12548000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7524000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6638000
CY2017 us-gaap Depreciation
Depreciation
1500000
CY2016 us-gaap Depreciation
Depreciation
1100000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2017 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P88M
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
830000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
830000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
830000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
830000
CY2017Q4 apvo Finite Lived Intangible Assets Amortization Expense Year Five And After
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter
2760000
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
35000000
CY2017 us-gaap Line Of Credit Facility Frequency Of Payment And Payment Terms
LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms
The loan repayment included interest (no principal) through August 2018 and was set to transition to principal and interest as of August 2018 and to be repaid in full on February 1, 2021 (54 months).
CY2016Q3 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P54M
CY2016Q3 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2021-02-01
CY2017 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR
CY2016Q3 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0760
CY2017Q1 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
20000000
CY2017Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1400000
CY2016Q3 apvo Credit Agreement Exit Fee Percentage
CreditAgreementExitFeePercentage
0.0575
CY2017Q2 apvo Credit Agreement Final Principal Payment Percentage
CreditAgreementFinalPrincipalPaymentPercentage
0.0675
CY2017Q2 apvo Credit Agreement Minimum Cash Threshold Required Amount
CreditAgreementMinimumCashThresholdRequiredAmount
25000000
CY2017Q4 apvo Payment Of Principal And Interest On Debt In Next Twelve Months
PaymentOfPrincipalAndInterestOnDebtInNextTwelveMonths
5050000
CY2017Q4 apvo Payment Of Principal And Interest On Debt In Year Two
PaymentOfPrincipalAndInterestOnDebtInYearTwo
9147000
CY2017Q4 apvo Payment Of Principal And Interest On Debt In Year Three
PaymentOfPrincipalAndInterestOnDebtInYearThree
8441000
CY2017Q4 apvo Payment Of Principal And Interest On Debt In Year Four
PaymentOfPrincipalAndInterestOnDebtInYearFour
2022000
CY2017Q4 apvo Payment Of Principal And Interest On Debt
PaymentOfPrincipalAndInterestOnDebt
24660000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4884000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3809000
CY2017 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2017 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
500000
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1713000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1611000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
543000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3867000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
371000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1262000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1128000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1726000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1246000
CY2017 apvo Percentage Limitation Of Taxable Income For Net Operating Losses Carryforward
PercentageLimitationOfTaxableIncomeForNetOperatingLossesCarryforward
0.800
CY2017 apvo Tax Cuts And Jobs Act Description
TaxCutsAndJobsActDescription
On December 22, 2017 the President of the United State signed into law Public Law No. 115-97, commonly referred to as the Tax Cuts and Jobs Act (the Tax Act), following its passage by the United States Congress. The Tax Act will make significant changes to U.S. federal income tax laws, including reduction of the corporate tax rate from 35.0% to 21.0%, limitation of the deduction for net operating losses to 80.0% of current year taxable income and elimination of net operating loss carrybacks, one-time taxation of offshore earning at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions.
CY2017 apvo Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
10000000
CY2017 apvo Tax Cuts And Jobs Act Of2017 Incomplete Accounting Tax Expense Related To Valuation Allowance
TaxCutsAndJobsActOf2017IncompleteAccountingTaxExpenseRelatedToValuationAllowance
0
CY2017 apvo Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
20000
CY2017 apvo Tax Cuts And Jobs Act Of2017 Incomplete Accounting Cumulative Foreign Earnings
TaxCutsAndJobsActOf2017IncompleteAccountingCumulativeForeignEarnings
60000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-12051000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-4255000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-710000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-218000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-2000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-29000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-12763000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-4502000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-9636000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-14518000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-902000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-672000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10538000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15190000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-55885000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-139578000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-8000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
8454000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
7237000
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
4470000
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
17464000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3050000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
502000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
384000
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
309000
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
160000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17371000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30392000
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
224000
CY2016Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
575000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
224000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
575000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17147000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29817000
CY2017Q4 us-gaap Deferred Tax Asset Parents Basis In Discontinued Operation
DeferredTaxAssetParentsBasisInDiscontinuedOperation
0
CY2016Q4 us-gaap Deferred Tax Asset Parents Basis In Discontinued Operation
DeferredTaxAssetParentsBasisInDiscontinuedOperation
10400000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.010
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.068
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.003
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.074
CY2016 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
-0.079
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.013
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.174
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.141

Files In Submission

Name View Source Status
0001564590-18-005384-index-headers.html Edgar Link pending
0001564590-18-005384-index.html Edgar Link pending
0001564590-18-005384.txt Edgar Link pending
0001564590-18-005384-xbrl.zip Edgar Link pending
apvo-10k_20171231.htm Edgar Link pending
apvo-20171231.xml Edgar Link completed
apvo-20171231.xsd Edgar Link pending
apvo-20171231_cal.xml Edgar Link unprocessable
apvo-20171231_def.xml Edgar Link unprocessable
apvo-20171231_lab.xml Edgar Link unprocessable
apvo-20171231_pre.xml Edgar Link unprocessable
apvo-ex1038_189.htm Edgar Link pending
apvo-ex105_281.htm Edgar Link pending
apvo-ex107_280.htm Edgar Link pending
apvo-ex231_599.htm Edgar Link pending
apvo-ex311_549.htm Edgar Link pending
apvo-ex312_548.htm Edgar Link pending
apvo-ex321_546.htm Edgar Link pending
apvo-ex322_547.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201803122312372953289.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending